Dr. Choudhury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Da930
Boston, MA 02215Phone+1 617-632-6328Fax+1 617-632-2165
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2012- Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2008
Columbia University Vagelos College of Physicians and SurgeonsClass of 2006
Certifications & Licensure
NH State Medical License 2024 - 2026
RI State Medical License 2022 - 2026
MA State Medical License 2009 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2019 May 29
- Abemaciclib With or Without Atezolizumab for mCRPC Start of enrollment: 2021 Aug 20
- Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC Start of enrollment: 2021 Jun 28
- Join now to see all
Publications & Presentations
PubMed
- 233 citationsStructural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.Srinivas R. Viswanathan, Gavin Ha, Andreas M. Hoff, Jeremiah Wala, Jian Carrot-Zhang
Cell. 2018-07-12 - 157 citationsCompound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.Anis A. Hamid, Kathryn P. Gray, Grace Shaw, Laura E. MacConaill, Carolyn Evan
European Urology. 2019-07-01 - 13 citationsA Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.Atish D Choudhury, Celestia S Higano, Johann S de Bono, Natalie Cook, Dana E Rathkopf
Clinical Cancer Research. 2022-06-01
Journal Articles
- Tumor Fraction in Cell-Free DNA as a Biomarker in Prostate CancerHeather A. Parsons, Atish D. Choudhury, Lauren C. Harshman, Daniel G. Stover, The Journal of Clinical Investigation
- A Dose Finding Clinical Trial of Cabozantinib (XL184) Administered in Combination with Abiraterone Acetate in Metastatic Castration‐Resistant Prostate CancerChristopher Sweeney, Lauren C Harshman, Mark Pomerantz, Brandon Bernard, Atish D Choudhury, Philip W Kantoff, The Prostate
Press Mentions
Here Are Warning Signs That Men Age 15-35 Need to Know About Testicular CancerApril 7th, 2023- The Combination of Pembrolizumab and Radium-223 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Atish ChouduryFebruary 26th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
